AKT-IN-27
AKT-IN-27 (4a) is a potential anticancer drug that functions by selectively targeting Akt-driven signaling pathways. It induces apoptosis by activating caspase-3, causing G2/M phase cell cycle arrest, and disrupting mitochondrial membrane potential. AKT-IN-27 (4a) is applicable in research on triple-negative breast cancer (TNBC) .
Product Specifications
Field of Research
Cell Biology, Signal Transduction
Smiles
O=C (C1=C2SC (NC3=CC=CC=C3) =C1C (OCC) =O) C4=CC=CC=C4C2=O
Molecular Formula
C21H15NO4S
Molecular Weight
377.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
